Carl Fredrik Ragmark

Part of Institut für Medizinische Diagnostik MVZ GbR, NORDMED Healthcare GmbH is a German company that operates a general practitioner clinic. The company is based in Berlin, Germany. The company was founded in 1992. The CEO is Staffan Percy Ternström.

PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

IMD MVZ Beteiligungs GmbH provides investment services. The private company is based in Berlin, Germany. The German company was founded in 2012. Benedikt von Braunmühl has been the CEO of the company since 2018.

IMD Institut für Medizinische Diagnostik GmbH is a medical laboratory company based in Berlin, Germany. and has subsidiaries in Germany. IMD Institut für Medizinische Diagnostik GmbH operates as medical laboratories. The CEO of the German company is Benedikt von Braunmühl.

Part of IMD Institut für Medizinische Diagnostik GmbH, Labormedicus GmbH provides health care services. The company is based in Rostock, Germany. The CEOs of the German company are Hagen Pommerenke, Kristian Meinck, Benedikt von Braunmühl.

HMNC Holding GmbH provides investment services. The company is based in Munich, Germany. The German company was founded by Florian Holsboer. Benedikt von Braunmühl has been the CEO of the company since 2021.

Hmnc Brain Health GmbH is a precision psychiatry biopharma German company that develops personalized therapies for major depressive disorder and treatment-resistant depression. The company is headquartered in Germany and has a presence in both Europe and the United States. Hmnc Brain Health is backed by a renowned VC, several family offices, and a strategic healthcare investor. The CEO of the private company is Benedikt von Braunmühl.

Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany.